The VACTERL association represents a complex, nonrandom cluster of congenital malformations encompassing vertebral defects, anorectal malformations, cardiac anomalies, tracheoesophageal fistula, renal malformations, and limb anomalies. Despite its clinical recognition, the underlying genetic causes and pathomechanisms remain largely elusive. The Mediator complex is an essential coactivator that bridges transcription factors with RNA polymerase II. Within this complex, the MED14 subunit serves as a key structural scaffold linking distinct modules. However, the developmental role of MED14 and its link to VACTERL pathogenesis remain unclear.
This study in Genes & Diseases by researchers from South China University of Technology, Anhui Medical University, Capital Institute of Pediatrics, and the Chinese Academy of Sciences investigated how med14 mutations contribute to VACTERL association by developing a zebrafish deficiency model, functionally characterizing a human MED14-I550V variant, and elucidating downstream molecular and genomic mechanisms.
Using CRISPR/Cas9-mediated gene editing, the researchers generated med14 -deficient zebrafish and found that loss of Med14 recapitulated VACTERL features, with mutants exhibiting multi-organ defects, including impaired cardiac looping, reduced cmlc2 expression, pectoral fin bud hypoplasia with loss of distal limb markers ( hoxa13a , hoxd13a ), blocked anal openings associated with reduced expression of evx1 and prdm1 , and severe pronephric kidney anomalies. Further developmental analyses indicated that early mesoderm formation was largely preserved, whereas subsequent cell-fate specification and organogenesis were disrupted. These findings suggested that Med14 is critical for transcriptional programs governing later stages of organogenesis.
To investigate a possible clinical connection, the authors identified a c.1648A>G (p.I550V) missense variant in MED14 in a two-month-old boy diagnosed with VACTERL association. The patient exhibited mesocardia, polydactyly, partial sacral loss, absent coccyx, imperforate anus, rectourethral fistula, vesicoureteral reflux, and hypospadias. His mother and asymptomatic maternal grandfather also carried the variant, illustrating the variable expressivity associated with VACTERL-related genetic factors. A corresponding Med14-I556V mouse model reproduced several VACTERL-like features, including mesocardia, shortened digits, absent coccygeal vertebrae, and reduced glomerular size, although with low penetrance.
Functional rescue experiments demonstrated that wild-type human or zebrafish Med14 could restore heart looping, cloacal development and function, and kidney-associated phenotypes in med14 -deficient zebrafish, while the human MED14-I550V variant showed markedly reduced rescue activity, supporting its functional impairment during development.
Biochemically, co-immunoprecipitation experiments showed that the MED14-I550V mutation directly weakens the physical interaction between MED14 and MED17 and MED7, key components of the Mediator complex, which reduces the association between the Mediator complex and RNA Polymerase II (RPB1). Furthermore, integrated ChIP-seq and RNA-seq analyses revealed that loss of Med14 resulted in 818 downregulated and 391 upregulated genes, with 164 genes identified as direct or proximal Med14 targets that were both bound by Med14 and downregulated in mutants. These targets were enriched in pathways associated with fin, bone, kidney, heart, and neural development. Among them, fancl , previously implicated in VACTERL association, showed loss of MED14 binding and transcriptional activity. Additional experiments demonstrated reduced Mediator/RNA polymerase II association and decreased expression of selected developmental genes in affected tissues.
Overall, the study establishes MED14 as an important regulator of fetal organogenesis and provides experimental evidence connecting disruption of the Mediator complex with VACTERL-like developmental abnormalities. The findings indicate that impaired MED14 function affects organogenesis through defective transcriptional regulation and altered cell-fate decisions rather than early mesoderm formation. The X-linked location of MED14 may also contribute to the male predominance of VACTERL association, while the variable phenotypes observed in the patient family and the low penetrance observed in mice highlight the likely influence of additional genetic and environmental factors.
Reference
Title of the original paper: Loss of med14 causes developmental malformations characteristic of VACTERL association by disrupting the Mediator complex
Journal: Genes & Diseases
Genes & Diseases is a journal for molecular and translational medicine. The journal primarily focuses on publishing investigations on the molecular bases and experimental therapeutics of human diseases. Publication formats include full length research article, review article, short communication, correspondence, perspectives, commentary, views on news, and research watch.
DOI: https://doi.org/10.1016/j.gendis.2025.101780
# # # # # #
Genes & Diseases publishes rigorously peer-reviewed and high quality original articles and authoritative reviews that focus on the molecular bases of human diseases. Emphasis is placed on hypothesis-driven, mechanistic studies relevant to pathogenesis and/or experimental therapeutics of human diseases. The journal has worldwide authorship, and a broad scope in basic and translational biomedical research of molecular biology, molecular genetics, and cell biology, including but not limited to cell proliferation and apoptosis, signal transduction, stem cell biology, developmental biology, gene regulation and epigenetics, cancer biology, immunity and infection, neuroscience, disease-specific animal models, gene and cell-based therapies, and regenerative medicine.
Scopus CiteScore: 10.4 | Impact Factor: 14.6
More information: https://www.keaipublishing.com/en/journals/genes-and-diseases/
Editorial Board: https://www.keaipublishing.com/en/journals/genes-and-diseases/editorial-board/
All issues and articles in press are available online in ScienceDirect ( https://www.sciencedirect.com/journal/genes-and-diseases ).
Submissions to Genes & Diseases may be made using Editorial Manager ( https://www.editorialmanager.com/gendis/default.aspx ).
Print ISSN: 2352-4820
eISSN: 2352-3042
CN: 50-1221/R
Contact Us: editor@genesndiseases.cn
X (formerly twitter): @GenesNDiseases ( https://x.com/GenesNDiseases )
Genes & Diseases